HOME
OUR FOCUS
OUR TEAM
NEWS
More
Bexson Biomedical Hires Veteran Medical Device Development Leader, Will Focus On New Dosing & Delivery Solutions For Controlled Substances
Bexson Biomedical Raises $4.8 Million In Oversubscribed Series A
Stevanato Group And Bexson Biomedical Announce Collaboration To Develop A Customized Wearable Ketamine Delivery Device
Forbes - This Wearable Ketamine Device Could be the Future of Pain Management
Bexson Biomedical To Co-Host Virtual Ketamine Conference
Bexson Biomedical Adds Industry Leaders Bill Carson And Noah Craft As Advisors
February 2021 -- Investor Presentation